Waldencast plc (NASDAQ:WALD) Receives $5.56 Average Price Target from Analysts

Shares of Waldencast plc (NASDAQ:WALD - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the six research firms that are presently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $5.40.

Several analysts recently issued reports on WALD shares. Telsey Advisory Group set a $5.00 price objective on shares of Waldencast in a research note on Thursday, March 20th. DA Davidson restated a "buy" rating and issued a $7.50 price target on shares of Waldencast in a research report on Wednesday, March 19th. Industrial Alliance Securities set a $5.00 price target on Waldencast in a report on Tuesday, April 22nd. Finally, Alliance Global Partners started coverage on Waldencast in a research note on Tuesday, April 22nd. They set a "buy" rating and a $5.00 price objective on the stock.

Institutional Trading of Waldencast

Institutional investors have recently made changes to their positions in the company. SG Americas Securities LLC purchased a new position in Waldencast in the fourth quarter worth approximately $42,000. Stonebrook Private Inc. acquired a new position in shares of Waldencast in the 4th quarter valued at $48,000. Ethic Inc. purchased a new position in shares of Waldencast during the 4th quarter worth $56,000. Wells Fargo & Company MN increased its position in shares of Waldencast by 29.9% during the 4th quarter. Wells Fargo & Company MN now owns 14,571 shares of the company's stock worth $59,000 after purchasing an additional 3,358 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Waldencast in the 4th quarter valued at about $70,000. Hedge funds and other institutional investors own 41.97% of the company's stock.

Waldencast Trading Down 4.6 %

Shares of Waldencast stock traded down $0.13 during trading hours on Tuesday, reaching $2.69. 42,958 shares of the company's stock were exchanged, compared to its average volume of 127,362. The business has a fifty day moving average of $2.94 and a two-hundred day moving average of $3.26. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78. Waldencast has a 1 year low of $2.31 and a 1 year high of $5.46.

Waldencast Company Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.